Related Experiment Video
Updated: Mar 11, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
microRNA-25 targets PKCζ and protects osteoblastic cells from dexamethasone via activating AMPK signaling
Jian-Bo Fan1,2, Wei Liu1, Xin-Hui Zhu1
1Department of Orthopaedics, The Second Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu, PR China.
Abstract:
AMP-activated protein kinase (AMPK) activation could protect osteoblasts from dexamethasone (Dex). This study aims to provoke AMPK activation via microRNA downregulation of its negative regulator protein kinase C ζ (PKCζ). Results show that microRNA-25-5p (miR-25-5p) targets PKCζ's 3' untranslated regions (UTRs). Forced-expression of miR-25 downregulated PKCζ and activated AMPK in human osteoblastic cells (OB-6 and hFOB1.19 lines), which thereafter protected cells from Dex. Reversely, expression of antagomiR-25, the miR-25 inhibitor, upregulated PKCζ and inhibited AMPK activation, exacerbating Dex damages. Notably, PKCζ shRNA knockdown similarly activated AMPK and protected osteoblastic cells from Dex. AMPK activation was required for miR-25-induced osteoblastic cell protection. AMPKα shRNA or dominant negative mutation almost completely blocked miR-25-induced cytoprotection against Dex. Further studies showed that miR-25 expression increased NADPH activity and suppressed Dex-induced oxidative stress in osteoblastic cells. Such effects by miR-25 were abolished with AMPKα knockdown or mutation. Significantly, miR-25-5p level was increased in patients' necrotic femoral head tissues, which was correlated with PKCζ downregulation and AMPK hyper-activation. These results suggest that miR-25-5p targets PKCζ and protects osteoblastic cells from Dex possibly via activating AMPK signaling.
Insights
MicroRNA-25-5p protects osteoblasts from dexamethasone by downregulating protein kinase C ζ (PKCζ), activating AMP-activated protein kinase (AMPK), and reducing oxidative stress.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Osteoblasts are crucial for bone health.
- Dexamethasone (Dex) can induce osteoblast damage.
- AMP-activated protein kinase (AMPK) activation shows potential for osteoblast protection.
Purpose of the Study:
- To investigate the role of microRNA-25-5p (miR-25-5p) in protecting osteoblasts from dexamethasone (Dex).
- To explore the mechanism involving protein kinase C ζ (PKCζ) and AMPK activation.
Main Methods:
- Utilized human osteoblastic cell lines (OB-6 and hFOB1.19).
- Manipulated miR-25-5p levels via forced expression and antagomiR-25.
- Assessed protein levels of PKCζ and AMPK activation.
- Investigated effects on NADPH activity and oxidative stress.
- Correlated findings with patient tissue samples.
Main Results:
- miR-25-5p targets and downregulates PKCζ in osteoblasts.
- miR-25-5p activation of AMPK protects osteoblasts from Dex-induced damage.
- PKCζ downregulation and AMPK activation are essential for miR-25-5p's protective effects.
- miR-25-5p increases NADPH activity and reduces oxidative stress, effects dependent on AMPK.
- Increased miR-25-5p levels and decreased PKCζ were observed in patient necrotic femoral head tissues.
Conclusions:
- miR-25-5p protects osteoblastic cells from dexamethasone.
- This protection is mediated by targeting PKCζ, leading to AMPK activation.
- The miR-25-5p/PKCζ/AMPK pathway represents a potential therapeutic target for dexamethasone-induced osteoblast injury.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades

